A carregar...
A Novel Tumor-Activated Prodrug Strategy Targeting Ferrous Iron Is Effective in Multiple Preclinical Cancer Models
[Image: see text] Here we describe a new approach for tumor targeting in which augmented concentrations of Fe(II) in cancer cells and/or the tumor microenvironment triggers drug release from an Fe(II)-reactive prodrug conjugate. The 1,2,4-trioxolane scaffold developed to enable this approach can in...
Na minha lista:
Publicado no: | J Med Chem |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
American Chemical
Society
2016
|
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5184369/ https://ncbi.nlm.nih.gov/pubmed/27936709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.jmedchem.6b01470 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|